Related Experiment Video
Updated: Jul 10, 2026

Enhanced Reduced Representation Bisulfite Sequencing for Assessment of DNA Methylation at Base Pair Resolution
Published on: February 24, 2015
[Relationship between RAR-beta gene expression defect and its methylation]
Yan-ping Gao1, Min Li, Ying-ying Zhang
1Department of Obstetrics and Gynecology, Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Objective:
To evaluate the expression of RAR-beta gene in cervical carcinoma cell lines SiHa, HeLa, C33A and Caski and to analyze the relation between their gene expression and the promoter methylation of RAR-beta DNA.
Methods:
The expression of mRNA and protein of RAR-beta gene in the four cell lines were analyzed by RT-PCR, western blot and immunofluorescence, respectively. Methylation specific PCR (MSP) was used to check whether there was methylation in the promoter of RAR-beta gene. The demethylating agent 5-aza-2'-deoxycytidine (5-Aza-cdR) was used to treat methylated cell lines and the change of RAR-beta gene methylation and RAR-beta gene expression defects were observed. The cell proliferation was assayed with 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide method.
Results:
The mRNA and protein expression levels of RAR-beta in cell lines SiHa, HeLa, Caski and C33A were 0.25 +/- 0.08, 0, 0.60 +/- 0.19, 3.12 +/- 0.92 and 0.23 +/- 0.07, 0, 0.14 +/- 0.05, 0.68 +/- 0.21, respectively. The mRNA and protein expression of RAR-beta in SiHa, HeLa and Caski cell lines were decreased or silenced, whereas its expression increased in C33A cell line. MSP method showed that there were RAR-beta gene methylation in SiHa, HeLa and Caski cell lines, while there was no RAR-beta gene methylation in C33A cell line. After treated with 5-Aza-cdR, the mRNA and protein expression levels of RAR-beta in SiHa, HeLa, Caski and C33A cell lines were 1.82 +/- 0.59, 2.13 +/- 0.62, 1.67 +/- 0.43, 2.95 +/- 0.89 and 0.69 +/- 0.21, 0.83 +/- 0.29, 0.56 +/- 0.16, 0.64 +/- 0.20 respectively. The mRNA and protein levels of RAR-beta had a significant difference between before and after interference with 5-Aza-cdR in SiHa, HeLa, and Caski cell lines (P < 0.05). However, they had no significant difference between before and after interference with 5-Aza-cdR in C33A cell line (P > 0.05). The 5-Aza-cdR treatment could suppress cell proliferation.
Conclusions:
The RAR-beta gene expression defects play an important role in the carcinogenesis of cervical cancer. Aberrant methylation in promotor region of RAR-beta gene may be an important mechanism for the loss of expression of RAR-beta gene.
Insights
RAR-beta gene expression defects are crucial in cervical cancer development. Promoter methylation of the RAR-beta gene is a key mechanism causing its reduced expression, impacting cancer progression.
Area of Science:
- Molecular Biology
- Oncology
- Epigenetics
Context:
- Cervical cancer is a significant global health concern.
- Retinoic acid receptor-beta (RAR-beta) is implicated in various cancers.
- Gene promoter methylation is a known epigenetic mechanism affecting gene expression.
Purpose:
- To investigate RAR-beta gene expression in cervical carcinoma cell lines.
- To determine the correlation between RAR-beta gene expression and its promoter methylation.
- To assess the effect of a demethylating agent on RAR-beta expression and cell proliferation.
Summary:
- RAR-beta mRNA and protein levels were evaluated in SiHa, HeLa, C33A, and Caski cell lines.
- Methylation-specific PCR revealed RAR-beta promoter methylation in SiHa, HeLa, and Caski cells, correlating with decreased expression.
- Treatment with 5-aza-2'-deoxycytidine (5-Aza-cdR) restored RAR-beta expression in methylated cell lines and suppressed proliferation.
Impact:
- RAR-beta gene expression defects are vital in cervical carcinogenesis.
- Aberrant RAR-beta promoter methylation is a significant mechanism for gene silencing.
- Findings suggest potential therapeutic strategies targeting epigenetic modifications in cervical cancer.
Related Concept Videos
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
MicroRNAs
MicroRNAs
Master Transcription Regulators

